Showing results (141-150 of 283) with videos related to
Sort By:
Pageof 29
Blood|October 1, 1994
Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemiaG Meloni, R Foa, M Vignetti, et al.Journal of Endocrinological Investigation|October 1, 1989
Immunoreactive beta-endorphin levels in cerebrospinal fluid of children with acute lymphoblastic leukemia: relationship with glucocorticoid therapy and neurological complicationsP Iannetti, A Fabbri, G Meloni, et al.Cancer|October 1, 1987
Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemiaM Fontana, C Stanton, A Pompili, et al.Phlebologie|April 1, 1993
[Loco-regional thrombolysis in deep venous thrombosis]D Palombo, C Porta, P Brustia, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 9, 2017
Sexual dysfunction and its determinants among women infected with HIVPatricia A Agaba, Seema T Meloni, Halima M Sule, et al.La Radiologia Medica|December 17, 2009
Dose reduction in multislice CT by means of bismuth shields: results of in vivo measurements and computed evaluationP Catuzzo, S Aimonetto, G Fanelli, et al.Blood|July 1, 1983
Reexpression of normal stem cells in erythroleukemia during remissionA M Ferraris, L Canepa, C Mareni, et al.Plos One|October 21, 2016
Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in NigeriaSeema T Meloni, Charlotte A Chang, Geoffrey Eisen, et al.Human Biology|April 1, 1996
Novel tetranucleotide repeat polymorphism in the human adenosine deaminase gene: interethnic comparison of three major human groupsR Scozzari, F Cruciani, P Santolamazza, et al.Leukemia|October 3, 2002
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administrationG Meloni, S M Trisolini, S Capria, et al.Pageof 29